5 Reasons Biotech Valuations Go Down When Inflation Goes Up (and what you can do about it)
Unfortunately for biotechnology companies, their products have long development timelines and are perceived to be a high-risk investment....
top of page
My Thoughts
Leveraging my experience as a co-founder of a biotechnology start-up, corporate development leader, and investor to discuss tactical and strategic considerations for building great biotech and pharma companies.
Search
bottom of page